Loading biomarkers…
Loading biomarkers…
Biomarkers
A biomarker entry is an identity record — what is measured, by which assay family, the NCIt concept it maps to and the gene it is anchored to. Every link to cancers, drugs, approvals and trials is derived at query time from curated evidence and registries; nothing on this page grades clinical utility or states a threshold of its own.
| Biomarker | Kind | Gene(s) | NCIt | Cancers | Drugs | Approvals | Tissue-agnostic | Active trials |
|---|---|---|---|---|---|---|---|---|
| BCMA (TNFRSF17)BCMA · B-cell maturation antigen · TNFRSF17 · CD269 | Cell-surface target | TNFRSF17 | C128845 | 0 | 0 | 3 | — | 0 |
| CD19CD19-positive · CD19 antigen · B-lymphocyte antigen CD19 | Cell-surface target | CD19 | C129255 | 0 | 0 | 4 | — | 0 |
| CD20 (MS4A1)CD20 · CD20-positive · MS4A1 · B-lymphocyte antigen CD20 | Cell-surface target | MS4A1 |
| 1 |
| 1 |
| 4 |
| — |
| 1 |
| CD30 (TNFRSF8)CD30 · CD30-positive · TNFRSF8 · Ki-1 antigen | Cell-surface target | TNFRSF8 | C129257 | 0 | 0 | 1 | — | 0 |
| CD33CD33-positive · Siglec-3 · myeloid cell surface antigen CD33 | Cell-surface target | CD33 | C132228 | 0 | 0 | 5 | — | 0 |
| CD38CD38-positive · ADP-ribosyl cyclase 1 | Cell-surface target | CD38 | C147087 | 0 | 0 | 14 | — | 0 |
| PSMA (FOLH1) expressionPSMA · FOLH1 · prostate-specific membrane antigen · PSMA-positive | Cell-surface target | FOLH1 | C153464 | 0 | 0 | 1 | — | 0 |
| Somatostatin receptor (SSTR) expressionSSTR · SSTR2 · somatostatin receptor-positive · SSTR imaging | Cell-surface target | SSTR2 | C128873 | 0 | 0 | 1 | — | 0 |
Data updated 19 days agoSource updated NCIt 26.08ecodes verified 2026-09-11
Counts are computed over ingested sources only (CIViC, ClinicalTrials.gov, openFDA, Health Canada, PubMed) and say nothing about biomarkers or links that are not yet ingested. A trial counted here tests a linked drug in a linked cancer; it does not necessarily select patients on the biomarker.